MedTrace Logo

Assessing Continuous Non- Invasive Blood Glucose Sensor- Physical Logic AG

NCT01247649 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2012-11-20

No results posted yet for this study

Summary

The present study is aimed to evaluate the feasibility of a new noninvasive method to measure continuous glucose values using electromagnetic radiation.

Conditions

Interventions

DEVICE

Physical Logic Continuous Glucose Monitoring System

Patients will be monitored to assess continuous blood glucose levels using the study device (Physical Logic) and reference methods, during 2-3 clinic visits, lasting 6-8 hours each

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Revital Nimri, Dr · Schenider Children's Medical

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01247649 on ClinicalTrials.gov